
Erin Schenk, MD, PhD
@schenklab
Thoracic Med Onc | Scientist @CUAnschutz | My lab studies the interface between the immune system and lung cancer | Immunotherapy enthusiast | @MayoHemeOnc Alum
ID: 1166120819811966976
https://www.cudoctors.com/Find_A_Doctor/Profile/27915 26-08-2019 22:50:51
222 Tweet
614 Followers
541 Following


Just out!! Congrats to CU Rad Onc and Brian Kavanagh. CNS downstaging continues to evolve. For pts with extensive brain mets (>30), upfront TKI and deferring WBRT reasonable. See here 👉🏾 sciencedirect.com/science/articl… #LCSM ALK+ International @ALKLungCancer EGFR Resisters The ROS1ders, Inc.


Highly recommend! The MBCO AACR course was an incredible opportunity to meet with other physician scientists, discuss opportunities and challenges unique to this path. Thank you Christine Lovly, MD, PhD, FASCO for encouraging me to apply




Thank you ALK Positive! Currently in the lab working towards new plans



Mayo Clinic Hematology-Oncology Fellowship gave me a thoracic oncology sister for life! Dr. Erin Schenk, MD, PhD Fancy breakfast and soulful conversations. #TTLC24



Don’t miss out! My colleague Tejas Patil presenting his exciting work on early MET bypass signaling in ALK and RET driven NSCLC. He is also an CU Cancer Center Rising Star! LUNGevity Foundation ALK Positive RETpositive #LCSM #AACR24


The promise of immune-based therapies still needs to reach patients with NSCLC bearing driver alterations. We need to look beyond checkpoint inhibitors. Thank you Narjust Florez, MD, FASCO and Biagio Ricciuti, MD PhD for the amazing discussion! #LCSM

